tm logo
NEXT LEVEL IMMUNO-ONCOLOGY
Live/Pending
EX PARTE APPEAL PENDING

on 06 Aug 2024

Last Applicant/ Owned by

900 Stewart Avenue, Suite 301

Garden City

BM

NY

11530

Serial Number

97207825 filed on 07th Jan 2022

Registration Number

N/A

Correspondent Address

LAURA J. WINSTON

Laura J. Winston Offit Kurman, P.A.

New York, NY 10022

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

NEXT LEVEL IMMUNO-ONCOLOGY

Scientific research for medical purposes in the area of tumors, cancer, and respiratory diseases; medical research services, namely, conducting clinical trials for others; scientific research, namely, research on the use of nitric oxide and ultra-high nitric oxide for medical purposes; Scientific research, namely, research on preparations and treatments for tumors, cancer, and respiratory diseases Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific research for medical purposes in the area of tumors, cancer, and respiratory diseases; medical research services, namely, conducting clinical trials for others; scientific research, namely, research on the use of nitric oxide and ultra-high nitric oxide for medical purposes; Scientific research, namely, research on preparations and treatments for tumors, cancer, and respiratory diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [010]
Medical Instrument Products


Medical apparatus and instruments for medical and therapeutic purposes, namely, a therapeutic immunotherapy system using ultra-high concentrations of nitric oxide for patients with solid tumors and other cancers to be treated in a hospital operating room or an outpatient setting; contained medical system composed of a cylinder, with a valve, comprising ultra-high concentrations of nitric oxide balanced with nitrogen gas for the treatment of solid tumors and other cancer, a delivery apparatus comprised of instruments for setting, measuring and regulating the mixture of medical and therapeutic gases, such as ultra-high concentrations of nitric oxide, delivered to patients, and co-packaged medical tubing and applicators materials capable of delivering nitric oxide to tumor tissue


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations and articles, namely, medical gas being nitric oxide for medical purpose to be used at home or in a hospital; gases for medical purposes, namely, nitric oxide for medical purposes and ultra-high nitric oxide for the treatment of tumors and cancer; chemical preparations for medical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; chemical preparations for pharmaceutical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Pharmaceutical preparations for treating tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Medical preparations for the treatment of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97207825

Mark Type

No Service Mark

Attorney Docket Number

No 9810001.0040

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
01st Nov 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
01st Nov 2024TEAS/EMAIL CORRESPONDENCE ENTERED
31st Oct 2024ASSIGNED TO LIE
06th Aug 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
06th Aug 2024EX PARTE APPEAL-INSTITUTED
06th Aug 2024EXPARTE APPEAL RECEIVED AT TTAB
06th Aug 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
03rd May 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
03rd May 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06th Feb 2024NOTIFICATION OF FINAL REFUSAL EMAILED